CD152 (CTLA-4) regulates effector functions of CD8+ T lymphocytes by repressing Eomesodermin

被引:29
作者
Hegel, Johannes X. [1 ,2 ]
Knieke, Karin [1 ,2 ]
Kolar, Paula [2 ]
Reiner, Steven L. [3 ]
Brunner-Weinzierl, Monika C. [1 ,2 ]
机构
[1] Otto Von Guericke Univ, Dept Pediat, D-39120 Magdeburg, Germany
[2] Charite, Dept Rheumatol & Clin Immunol, Berlin, Germany
[3] Univ Penn, Dept Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA
关键词
CD8; Costimulation; Cytotoxicity; Inhibitory receptors; Transcription factors; IFN-GAMMA PRODUCTION; STOP-SIGNAL; CELLS; BET; ACTIVATION; EXPRESSION; BLOCKADE; MICE; DIFFERENTIATION; MELANOMA;
D O I
10.1002/eji.200838770
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
CD8(+) T lymphocytes are required for effective host defense against pathogens and also for mediating effector responses against uncontrolled proliferating self-tissues. in this study, we determine that individual CD8(+) T cells are tightly controlled in their effector functions by CD152 (CTLA-4). We demonstrate that signals induced by CD152 reduce the frequency of IFN-gamma and granzyme B expressing CD8(+) T cells independently of the transcription factors T-bet or cKrox by selectively inhibiting accumulation of Eomesodermin mRNA and protein. Ectopic expression of Eomesodermin reversed the CD152-mediated inhibition of effector molecule production. Additionally, enhanced cytotoxicity of individual CD8(+) T cells differentiated in the absence of CD152 signaling was determined in vivo. These novel insights extend our understanding of how immune responses of CD8(+) T cells are selectively modulated.
引用
收藏
页码:883 / 893
页数:11
相关论文
共 36 条
[1]
T-cell regulation by CD28 and CTLA-4 [J].
Alegre, ML ;
Frauwirth, KA ;
Thompson, CB .
NATURE REVIEWS IMMUNOLOGY, 2001, 1 (03) :220-228
[2]
Bachmann MF, 1998, J IMMUNOL, V160, P95
[3]
In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination [J].
Bonifaz, LC ;
Bonnyay, DP ;
Charalambous, A ;
Darguste, DI ;
Fujii, SI ;
Soares, H ;
Brimnes, MK ;
Moltedo, B ;
Moran, TM ;
Steinman, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (06) :815-824
[4]
Cytotoxic T lymphocyte antigen 4 (CTLA-4) interferes with extracellular signal-regulated kinase (ERK) and Jun NH4-terminal kinase (JNK) activation, but does not affect phosphorylation of T cell receptor zeta and ZAP70 [J].
Calvo, CR ;
Amsen, D ;
Kruisbeek, AM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (10) :1645-1653
[5]
Chambers CA, 1998, EUR J IMMUNOL, V28, P3137, DOI 10.1002/(SICI)1521-4141(199810)28:10<3137::AID-IMMU3137>3.3.CO
[6]
2-O
[7]
Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells [J].
Chambers, CA ;
Sullivan, TJ ;
Allison, JP .
IMMUNITY, 1997, 7 (06) :885-895
[8]
CTLA-4: new insights into its biological function and use in tumor immunotherapy [J].
Egen, JG ;
Kuhns, MS ;
Allison, JP .
NATURE IMMUNOLOGY, 2002, 3 (07) :611-618
[9]
Absence of CTLA-4 lowers the activation threshold of primed CD8+ TCR-transgenic T cells:: Lack of correlation with Src homology domain 2-containing protein tyrosine phosphatase [J].
Gajewski, TF ;
Fallarino, F ;
Fields, PE ;
Rivas, F ;
Alegre, ML .
JOURNAL OF IMMUNOLOGY, 2001, 166 (06) :3900-3907
[10]
Recent developments in the transcriptional regulation of cytolytic effector cells [J].
Glimcher, LH ;
Townsend, MJ ;
Sullivan, BM ;
Lord, GM .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (11) :900-911